Squarepoint’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $788K | Sell |
21,683
-198,201
| -90% | -$7.21M | ﹤0.01% | 1656 |
|
|
2025
Q1 | $7.96M | Buy |
219,884
+131,895
| +150% | +$4.78M | 0.01% | 608 |
|
|
2024
Q4 | $3.7M | Buy |
+87,989
| New | +$3.7M | ﹤0.01% | 898 |
|
|
2024
Q3 | – | Sell |
-18,585
| Closed | -$764K | – | 2939 |
|
|
2024
Q2 | $764K | Sell |
18,585
-38,540
| -67% | -$1.58M | ﹤0.01% | 1504 |
|
|
2024
Q1 | $2.67M | Buy |
57,125
+41,284
| +261% | +$1.93M | ﹤0.01% | 937 |
|
|
2023
Q4 | $758K | Buy |
+15,841
| New | +$758K | ﹤0.01% | 1488 |
|
|
2023
Q3 | – | Sell |
-11,558
| Closed | -$533K | – | 2777 |
|
|
2023
Q2 | $533K | Buy |
+11,558
| New | +$533K | ﹤0.01% | 1567 |
|
|
2023
Q1 | – | Sell |
-5,597
| Closed | -$259K | – | 2684 |
|
|
2022
Q4 | $259K | Sell |
5,597
-120,314
| -96% | -$5.57M | ﹤0.01% | 1763 |
|
|
2022
Q3 | $5.21M | Buy |
125,911
+73,806
| +142% | +$3.06M | 0.03% | 446 |
|
|
2022
Q2 | $3.11M | Buy |
52,105
+21,527
| +70% | +$1.28M | 0.02% | 590 |
|
|
2022
Q1 | $2.22M | Buy |
+30,578
| New | +$2.22M | 0.01% | 756 |
|
|
2021
Q3 | – | Sell |
-67,005
| Closed | -$6.39M | – | 2655 |
|
|
2021
Q2 | $6.39M | Buy |
67,005
+63,355
| +1,736% | +$6.04M | 0.02% | 406 |
|
|
2021
Q1 | $416K | Buy |
+3,650
| New | +$416K | ﹤0.01% | 1655 |
|
|
2020
Q4 | – | Sell |
-33,537
| Closed | -$2.76M | – | 2813 |
|
|
2020
Q3 | $2.76M | Buy |
33,537
+26,663
| +388% | +$2.19M | 0.04% | 517 |
|
|
2020
Q2 | $538K | Sell |
6,874
-7,543
| -52% | -$590K | 0.01% | 1272 |
|
|
2020
Q1 | $641K | Sell |
14,417
-45,299
| -76% | -$2.01M | 0.02% | 905 |
|
|
2019
Q4 | $2.55M | Buy |
59,716
+49,020
| +458% | +$2.09M | 0.02% | 742 |
|
|
2019
Q3 | $458K | Buy |
10,696
+2,211
| +26% | +$94.7K | ﹤0.01% | 1603 |
|
|
2019
Q2 | $539K | Buy |
+8,485
| New | +$539K | 0.01% | 1583 |
|
|
2019
Q1 | – | Sell |
-32,253
| Closed | -$1.4M | – | 2331 |
|
|
2018
Q4 | $1.4M | Buy |
+32,253
| New | +$1.4M | 0.02% | 793 |
|
|
2017
Q4 | – | Sell |
-6,600
| Closed | -$352K | – | 2286 |
|
|
2017
Q3 | $352K | Buy |
+6,600
| New | +$352K | 0.01% | 1093 |
|
|
2017
Q2 | – | Sell |
-3,660
| Closed | -$248K | – | 1745 |
|
|
2017
Q1 | $248K | Buy |
3,660
+267
| +8% | +$18.1K | 0.01% | 1177 |
|
|
2016
Q4 | $239K | Sell |
3,393
-14,307
| -81% | -$1.01M | 0.01% | 1300 |
|
|
2016
Q3 | $1.26M | Buy |
17,700
+9,600
| +119% | +$681K | 0.08% | 289 |
|
|
2016
Q2 | $396K | Buy |
8,100
+2,452
| +43% | +$120K | 0.02% | 631 |
|
|
2016
Q1 | $358K | Buy |
5,648
+3,448
| +157% | +$219K | 0.03% | 753 |
|
|
2015
Q4 | $247K | Buy |
+2,200
| New | +$247K | 0.03% | 891 |
|